Novavax Files Definitive Proxy Statement
Ticker: NVAX · Form: DEFA14A · Filed: Apr 30, 2025 · CIK: 1000694
| Field | Detail |
|---|---|
| Company | Novavax Inc (NVAX) |
| Form Type | DEFA14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
Related Tickers: NVAX
TL;DR
NOVAVAX proxy statement is out, shareholders vote soon on directors & company stuff.
AI Summary
Novavax, Inc. filed a Definitive Proxy Statement (DEFA14A) on April 30, 2025, detailing information for its upcoming shareholder meeting. The filing outlines the company's governance, executive compensation, and proposals requiring shareholder approval. Key details regarding director nominations and other corporate actions are expected to be presented to shareholders for their vote.
Why It Matters
This filing is crucial for shareholders as it provides the official information needed to understand and vote on important company matters, including director elections and corporate governance proposals.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEFA14A) providing information to shareholders, not a filing that inherently introduces new financial risk.
Key Players & Entities
- NOVAVAX INC (company) — Registrant
- 0001104659-25-041634.txt (document) — Filing identifier
- 20250430 (date) — Filing date
- 240-268-2000 (phone_number) — Business phone number
FAQ
What type of filing is this DEFA14A for Novavax, Inc.?
This is a Definitive Proxy Statement filed by Novavax, Inc. under Schedule 14A, pursuant to Section 14(a) of the Securities Exchange Act of 1934.
When was this filing submitted to the SEC?
The filing was submitted on April 30, 2025.
What is Novavax, Inc.'s primary business as indicated by the SIC code?
Novavax, Inc.'s Standard Industrial Classification (SIC) code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Where is Novavax, Inc. headquartered?
Novavax, Inc. is headquartered at 700 Quince Orchard Road, Gaithersburg, MD 20878.
What is the purpose of a DEFA14A filing?
A DEFA14A filing (Definitive Proxy Statement) provides shareholders with information they need to vote on matters at a company's annual or special meeting, such as the election of directors and executive compensation.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 30, 2025 regarding NOVAVAX INC (NVAX).